Benefit and Tolerability of a Probiotic Product in Infants With Abdominal Discomfort

NCT01893814 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2016-09-22

No results posted yet for this study

Summary

To demonstrate benefit and tolerability of a probiotic product in infants with abdominal discomfort.

Conditions

  • Abdominal Discomfort

Interventions

DIETARY_SUPPLEMENT

Probiotics

DIETARY_SUPPLEMENT

Control

Sponsors & Collaborators

  • Probi AB

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Weeks
Max Age
12 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01893814 on ClinicalTrials.gov